Total Payments
$6,718
2024 Payments
$993.71
Companies
48
Transactions
363
Medicare Patients
6,804
Medicare Billing
$712,093
Payment Breakdown by Category
Food & Beverage$6,381 (95.0%)
Consulting$227.08 (3.4%)
Education$110.29 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,381 | 358 | 95.0% |
| Consulting Fee | $227.08 | 1 | 3.4% |
| Education | $110.29 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,012 | 51 | $0 (2024) |
| Antares Pharma, Inc. | $677.58 | 64 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $622.84 | 31 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $522.14 | 25 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $499.05 | 27 | $0 (2022) |
| Janssen Biotech, Inc. | $271.89 | 15 | $0 (2024) |
| NeoTract Inc. | $241.19 | 2 | $0 (2018) |
| Boston Scientific Corporation | $231.89 | 11 | $0 (2024) |
| UROGEN PHARMA, INC. | $207.42 | 7 | $0 (2024) |
| ABBVIE INC. | $170.10 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $993.71 | 47 | Sumitomo Pharma America, Inc. ($287.59) |
| 2023 | $904.36 | 38 | Sumitomo Pharma America, Inc. ($335.25) |
| 2022 | $1,078 | 66 | Antares Pharma, Inc. ($235.88) |
| 2021 | $1,167 | 63 | Astellas Pharma US Inc ($178.68) |
| 2020 | $242.19 | 14 | Antares Pharma, Inc. ($70.14) |
| 2019 | $666.23 | 48 | Dendreon Pharmaceuticals LLC ($174.67) |
| 2018 | $765.00 | 47 | Gilead Sciences, Inc. ($114.23) |
| 2017 | $901.82 | 40 | NeoTract Inc. ($227.08) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/10/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Urology | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: UROLOGY | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: rezum_URO | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Oncology | ||||||
| 08/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/05/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: UROLOGY | ||||||
| 07/12/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $25.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,183 | 1,677 | $382,174 | $122,112 |
| 2022 | 24 | 1,741 | 2,383 | $540,469 | $190,291 |
| 2021 | 24 | 1,953 | 2,599 | $582,851 | $210,450 |
| 2020 | 25 | 1,927 | 2,723 | $577,832 | $189,240 |
Total Patients
6,804
Total Services
9,382
Medicare Billing
$712,093
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 176 | 197 | $94,667 | $36,213 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 240 | $59,760 | $21,628 | 36.2% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 23 | 24 | $75,082 | $13,315 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 151 | $26,266 | $8,825 | 33.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 23 | 276 | $26,496 | $8,149 | 30.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 58 | $23,296 | $7,619 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $18,630 | $6,269 | 33.7% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 22 | 22 | $14,549 | $5,818 | 40.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 23 | 23 | $11,020 | $4,172 | 37.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $7,916 | $2,449 | 30.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 27 | 30 | $4,701 | $1,862 | 39.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 26 | $3,316 | $1,302 | 39.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 35 | 36 | $4,116 | $1,099 | 26.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 24 | 24 | $4,128 | $1,056 | 25.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 261 | 317 | $1,324 | $695.21 | 52.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 36 | $1,274 | $371.20 | 29.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 18 | $1,228 | $356.98 | 29.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 14 | 15 | $2,195 | $266.22 | 12.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 14 | $637.00 | $262.64 | 41.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 25 | 25 | $604.00 | $217.75 | 36.1% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 22 | 44 | $808.00 | $84.42 | 10.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $161.00 | $78.43 | 48.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 209 | 235 | $98,935 | $43,647 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 416 | $87,360 | $38,125 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 251 | 301 | $45,150 | $17,474 | 38.7% |
About Dr. Jeffrey Zapinsky, M.D
Dr. Jeffrey Zapinsky, M.D is a Urology healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366537144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Zapinsky, M.D has received a total of $6,718 in payments from pharmaceutical and medical device companies, with $993.71 received in 2024. These payments were reported across 363 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,381).
As a Medicare-enrolled provider, Zapinsky has provided services to 6,804 Medicare beneficiaries, totaling 9,382 services with total Medicare billing of $712,093. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Henderson, NV
- Active Since 10/04/2006
- Last Updated 07/30/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366537144
Products in Payments
- GEMTESA (Drug) $570.56
- PROVENGE (Drug) $560.60
- XIAFLEX (Biological) $432.68
- XTANDI (Drug) $404.91
- Myrbetriq (Drug) $370.19
- XYOSTED (Drug) $308.28
- ORGOVYX (Drug) $277.87
- Urolift - UL400 (Device) $227.08
- NOCDURNA (Drug) $226.95
- Xtandi (Drug) $212.13
- JELMYTO (Drug) $207.42
- Erleada (Drug) $163.47
- Natesto (Drug) $137.77
- MYRBETRIQ (Drug) $127.80
- ERLEADA (Drug) $108.42
- Vabomere (Drug) $105.98
- Androgel (Drug) $96.38
- Noctiva (Drug) $95.99
- Nubeqa (Drug) $94.82
- SpeediCath (Device) $93.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Henderson
Dr. Casey Mccraw, M.d, M.D
Urology — Payments: $99,246
Urology $99,246
Dr. Guillermo Patino, D.o, D.O
Urology — Payments: $21,483
Urology $21,483
Scott Baranoff, M.d, M.D
Urology — Payments: $9,680
Urology $9,680
Dr. Adrian Ogle, Md, MD
Urology — Payments: $8,958
Urology $8,958
Michael Finkelstein, M.d, M.D
Urology — Payments: $4,736
Urology $4,736
James Fellows, Md, MD
Urology — Payments: $3,278
Urology $3,278